Baseline lipid profile is associated with adverse outcomes in adults with coronary artery disease and obstructive sleep apnea despite lipid-lowering drugs and CPAP treatment : A secondary analysis of the RICCADSA cohort
Background: Reducing lipid levels is essential for preventing major adverse cardiovascular and cerebrovascular events (MACCE) in management of coronary artery disease (CAD) patients with obstructive sleep apnea (OSA). The first line treatment of OSA is continuous positive airway pressure (CPAP), however, its impact on the association between lipid profile and MACCEs is uncertain. Methods: This was